Precision Medicine News and Research

RSS

Genetic risk score could help predict patient's quality of life after traumatic brain injury

A new study presented this week at the Association of Academic Physiatrists Annual Meeting in Atlanta found that a genetic risk score could help predict a patient's quality of life after a traumatic brain injury. One day, physicians could have a simple, early method to forecast a patient's recovery and personalize therapy to maximize their quality of life down the road.

15 Feb 2018

Scientists test how pathogens interact with artificial organs

Scientists at Imperial College London have become the first in the world to test how pathogens interact with artificial human organs.

14 Feb 2018

Organ chip technology improves study of the intestine for personalized medicine

Researchers have developed an organ-on-a-chip device using donor-derived human intestinal cells that offers advantages over organoids and new possibilities for personalized medicine.

14 Feb 2018

Using Smartphones for Cancer Diagnosis and Management

Dr. Castro is a translational oncologist with experience developing and harnessing nanotechnology and molecular imaging platforms for cancer purposes. His work offers a “less is more” approach — to generate robust cancer analyses using scant amount of specimens. Dr. Castro’s research has included funding from the V Foundation for Cancer Research, National Institutes of Health, Ovarian Cancer Research Fund, and the Department of Defense.

From Pittcon 14 Feb 2018

IBBL joins new € 3.13 million project to promote personalized medicine in Europe

IBBL will over the next three years contribute to the Interreg project Codex4SMEs. The € 3.13 million project aims to build a transnational network to accelerate the development of so-called companion diagnostics by small and medium-sized businesses and hence to promote personalized medicine in Europe.

13 Feb 2018

Professor Jean-Charles Soria granted award for pioneering role in cancer drug development

The TAT 2018 Honorary Award for cancer drug development has been granted to Professor Jean-Charles Soria, for his pioneering role in cancer drug development across molecular targeted agents, precision medicine, and immunotherapy.

12 Feb 2018

GlobalData reveals increasing demand for IVD testing as focus on personalized medicine becomes the norm

The in vitro diagnostic testing market is one of the fastest-growing segments within the medtech industry.

12 Feb 2018

Lesser-known CRS-HIPEC treatment for cancers that have spread to abdominal cavity

While cancer treatment advances are being made in the areas of precision medicine and immunotherapy, a unique combination of traditional therapies can also provide some cancer patients a treatment option that may provide significant benefit.

11 Feb 2018

Study of men with inherited DNA repair mutations opens new therapeutic avenues in prostate cancer

Selected by the American Society of Clinical Oncology to first outing during its Genitourinary Cancers Symposium, Translating Evidence to Multidisciplinary Care, February 8 - 10 (San Francisco, USA), Joaquin Mateo, Principal Investigator of VHIO's recently created Prostate Cancer Translational Research Group, will today reveal findings from a retrospective and international study showing for the first time that patients with inherited DNA repair mutations benefit from standard therapies in a similar way to other metastatic prostate cancer patients.

9 Feb 2018

Myriad’s myRisk Hereditary Cancer test finds inherited gene mutations in more than 12% of prostate cancer patients

Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, announced today that results from a large 1,162 patient study of the Myriad myRisk Hereditary Cancer test will be featured during the poster presentation at the 2018 Genitourinary Cancer Symposium in San Francisco, Calif.

8 Feb 2018

New partnership to evaluate effectiveness of diagnostic blood test for type 2 diabetes

A new partnership in Leeds has been agreed to evaluate the benefits of a diagnostic blood test which can help predict whether someone is likely to develop type 2 diabetes.

7 Feb 2018

Scientists develop new system to match genetic anomalies with precision medicine treatments

A team of computer scientists from the University of Delaware and Georgetown University has developed a new system to rapidly determine which cancer drugs are likely to work best given a patient's genetic markers.

6 Feb 2018

German researchers find way to accurately differentiate prostate cancer from benign tissue

Using nuclear medicine, German researchers have found a way to accurately differentiate cancerous tissue from healthy tissue in prostate cancer patients. The research is highlighted in the February issue of The Journal of Nuclear Medicine.

6 Feb 2018

Mitochondrial DNA may play more important role in metastatic cancer than previously thought

DNA found in the mitochondria may play a more significant role in metastatic cancer than originally thought.

6 Feb 2018

Researchers develop new method for producing personalized medicine

For the last 100 years, researchers have constantly pushed the boundaries for our knowledge about medicine and how different bodies can respond differently to it.

2 Feb 2018

RCSI to lead major study for finding new ways to treat colorectal cancer patients

RCSI is leading an international team of scientists on a major research study “COLOSSUS” which aims to provide new and more effective ways to classify and treat patients with colorectal cancer.

2 Feb 2018

New modular platform offers robust biological approach that targets endless number of diseases

The biological complexity of cancer and other diseases demands a more formidable arsenal of therapies than currently available. Most therapeutic approaches ignore the dynamic molecular network of genes, targeting instead only very few selected disease-related genes.

1 Feb 2018

Researchers win $6.5 million NIH grant to personalize diagnosis and treatment of psoriasis

An experienced interdisciplinary team of psoriasis and computational researchers from Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center has received a $6.5M, 5-year grant from the National Institute of Arthritis, Musculoskeletal and Skin Diseases.

29 Jan 2018

CureMatch’s co-founder is co-author of new article in Cancer Discovery journal

Igor F. Tsigelny, Ph.D., Co-founder and Chief Strategic Officer at CureMatch and research professor at University of California, San Diego, is a co-author of “Genomic landscape of cell-free DNA in patients with colorectal cancer” in Cancer Discovery along with group of colleagues from Duke University Medical Center, University of Texas MD Anderson Cancer Center, Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, Caris Life Sciences, and Guardant Health, Inc. organized by the Drs. Ryan B. Corcoran and Scott Kopetz.

27 Jan 2018

UTokyo enters into agreement for developing personalized cancer vaccine

The University of Tokyo entered an agreement for developing a personalized cancer vaccine using a novel method involving the body's immune response.

25 Jan 2018

Precision Medicine News and Research

Genetic risk score could help predict patient's quality of life after traumatic brain injury

Scientists test how pathogens interact with artificial organs

Organ chip technology improves study of the intestine for personalized medicine

Using Smartphones for Cancer Diagnosis and Management

IBBL joins new € 3.13 million project to promote personalized medicine in Europe

Professor Jean-Charles Soria granted award for pioneering role in cancer drug development

GlobalData reveals increasing demand for IVD testing as focus on personalized medicine becomes the norm

Lesser-known CRS-HIPEC treatment for cancers that have spread to abdominal cavity

Study of men with inherited DNA repair mutations opens new therapeutic avenues in prostate cancer

Myriad’s myRisk Hereditary Cancer test finds inherited gene mutations in more than 12% of prostate cancer patients

New partnership to evaluate effectiveness of diagnostic blood test for type 2 diabetes

Scientists develop new system to match genetic anomalies with precision medicine treatments

German researchers find way to accurately differentiate prostate cancer from benign tissue

Mitochondrial DNA may play more important role in metastatic cancer than previously thought

Researchers develop new method for producing personalized medicine

RCSI to lead major study for finding new ways to treat colorectal cancer patients

New modular platform offers robust biological approach that targets endless number of diseases

Researchers win $6.5 million NIH grant to personalize diagnosis and treatment of psoriasis

CureMatch’s co-founder is co-author of new article in Cancer Discovery journal

UTokyo enters into agreement for developing personalized cancer vaccine

Event guide: The 4th Precision Medicine in Inflammatory Bowel Disease Summit eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News